Gerald G. Krueger has not added Biography.
If you are Gerald G. Krueger and would like to personalize this page please email our Author Liaison for assistance.
Biology of Langerhans cells: selective migration of Langerhans cells into allogeneic and xenogeneic grafts on nude mice.
Proceedings of the National Academy of Sciences of the United States of America Mar, 1983 | Pubmed ID: 6572931
Impact of obesity and smoking on psoriasis presentation and management.
Archives of dermatology Dec, 2005 | Pubmed ID: 16365253
Observations of psoriasis in the absence of therapeutic intervention identifies two unappreciated morphologic variants, thin-plaque and thick-plaque psoriasis, and their associated phenotypes.
The Journal of investigative dermatology Nov, 2006 | Pubmed ID: 16858419
A multicenter, open-label study of repeat courses of intramuscular alefacept in combination with other psoriasis therapies in patients with chronic plaque psoriasis.
The Journal of dermatological treatment , 2008 | Pubmed ID: 18569270
Association between IL13 polymorphisms and psoriatic arthritis is modified by smoking.
The Journal of investigative dermatology Dec, 2009 | Pubmed ID: 19554022
Multiple Loci within the major histocompatibility complex confer risk of psoriasis.
PLoS genetics Aug, 2009 | Pubmed ID: 19680446
Obesity in early adulthood as a risk factor for psoriatic arthritis.
Archives of dermatology Jul, 2010 | Pubmed ID: 20644032
Dermatologist preferences for first-line therapy of moderate to severe psoriasis in healthy adult patients.
Journal of the American Academy of Dermatology Mar, 2012 | Pubmed ID: 21856040
Genome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL.
The Journal of investigative dermatology Apr, 2012 | Pubmed ID: 22170493
Ustekinumab: a review in the treatment of plaque psoriasis and psoriatic arthritis.
Journal of drugs in dermatology : JDD Feb, 2012 | Pubmed ID: 22270196
Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting.
Archives of dermatology Apr, 2012 | Pubmed ID: 22508874
Dermatologist preferences for treatments to compare in future randomized controlled comparative effectiveness trials for moderate to severe psoriasis.
Archives of dermatology Apr, 2012 | Pubmed ID: 22508884
Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis.
American journal of human genetics May, 2012 | Pubmed ID: 22521419
Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis.
Journal of the American Academy of Dermatology Jan, 2013 | Pubmed ID: 22846688
Variation in dermatologist beliefs about the safety and effectiveness of treatments for moderate to severe psoriasis.
Journal of the American Academy of Dermatology Feb, 2013 | Pubmed ID: 22910105
Using Hawthorne effects to improve adherence in clinical practice: lessons from clinical trials--reply.
JAMA dermatology Apr, 2013 | Pubmed ID: 23715064
Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis.
Journal of the American Academy of Dermatology Oct, 2014 | Pubmed ID: 24894455
Patient-reported outcomes for psoriasis patients with clear versus almost clear skin in the clinical setting.
Journal of the American Academy of Dermatology Oct, 2014 | Pubmed ID: 24928705
Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting.
Journal of the American Academy of Dermatology Dec, 2014 | Pubmed ID: 25260564
Desired Improvement Tool (DIT): A tool to assess desire for improvement in psoriasis patients.
The Journal of dermatological treatment , 2016 | Pubmed ID: 26247843
From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis.
Journal of the American Academy of Dermatology Feb, 2017 | Pubmed ID: 27908543
The Physician Global Assessment and Body Surface Area composite tool is a simple alternative to the Psoriasis Area and Severity Index for assessment of psoriasis: post hoc analysis from PRISTINE and PRESTA.
Psoriasis (Auckland, N.Z.) , 2018 | Pubmed ID: 30324088
Effect of Costimulatory Blockade With Abatacept After Ustekinumab Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: The PAUSE Randomized Clinical Trial.
JAMA dermatology Nov, 2021 | Pubmed ID: 34643650
PAPRIKA: A Question Bank for Assessing Psoriatic Arthritis Risk in Individuals of Diverse Ancestries.
Arthritis care & research Mar, 2024 | Pubmed ID: 37691268
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados